https://www.selleckchem.com/pr....oducts/ro-20-1724.ht
Healthcare professionals need to be aware of cancer survivors' concerns and uncertainties to provide appropriate care.We aimed to compare the efficacy of two different starting doses of recombinant follicle stimulating hormone (rFSH), 37.5 vs. 75 international units (IU) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS). A total of 109 women who underwent first rFSH stimulated IUI cycle were included in this retrospective cohort study. The primary outcome measure was the clinical preg
Like
Comment
Share
